Zebrafish as an innovative model for neuroendocrine tumors

Endocrine-Related Cancer

Volumn 21, Issue 1, 2014, Pages

  Vitale, Giovanni ^a,b   Gaudenzi, Germano ^a   Dicitore, Alessandra ^b   Cotelli, Franco ^a   Ferone, Diego ^c   Persani, Luca ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Angiogenesis; Neuroendocrine tumors; Somatostatin receptors; Tumor xenografts; Zebrafish

Indexed keywords

DOPAMINE RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; SOMATOSTATIN RECEPTOR;

ANGIOGENESIS; ANGIOGENESIS ASSAY; BLOOD VESSEL; CANCER CELL CULTURE; CANCER GRAFT; CANCER MODEL; CANCER RESEARCH; CARDIOVASCULAR SYSTEM; HUMAN; HUMAN CELL; MAMMAL; NEUROENDOCRINE TUMOR; NONHUMAN; REVIEW; TUMOR XENOGRAFT; ZEBRA FISH;

ANGIOGENESIS; NEUROENDOCRINE TUMORS; SOMATOSTATIN RECEPTORS; TUMOR XENOGRAFTS; ZEBRAFISH;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEUROENDOCRINE TUMORS; TRANSPLANTATION, HETEROLOGOUS; ZEBRAFISH;

EID: 84893575369     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0388     Document Type: Review

References (98)

1. Adams RH & Alitalo K 2007 Molecular regulation of angiogenesis and lymphangiogenesis. Nature Reviews. Molecular Cell Biology 8 464-478. (doi:10.1038/nrm2183)
2. Aflorei E, Chen C, McGonnell I, Fowkes R, Grossman A, Tapon N, Stanewsky R & Korbonits M 2012 Development of novel AIP (aryl hydrocarbon receptor-interacting protein) gene study models using the fruitfly and the zebrafish. Endocrine Abstracts 29 P1334.
3. Amatruda JF, Shepard JL, Stern HM & Zon LI 2002 Zebrafish as a cancer model system. Cancer Cell 1 229-231. (doi:10.1016/S1535-6108 (02)00052-1)
4. Bai X, Kim J, Yang Z, Jurynec MJ, Akie TE, Lee J, LeBlanc J, Sessa A, Jiang H, DiBiase A et al. 2010 TIF1γ controls erythroid cell fate by regulating transcription elongation. Cell 142 133-143. (doi:10.1016/j.cell.2010. 05.028)
5. Barreto-Valer K, Lopez-Bellido R, Macho Sanchez-Simon F & Rodriguez RE 2012 Modulation by cocaine of dopamine receptors through miRNA-133b in zebrafish embryos. PLoS ONE 7 e52701. (doi:10.1371/journal. pone.0052701)
6. Bedell VM, Wang Y, Campbell JM, Poshusta TL, Starker CG, Krug RG II, Tan W, Penheiter SG, Ma AC, Leung AY et al. 2012 In vivo genome editing using a high-efficiency TALEN system. Nature 491 114-118. (doi:10.1038/nature11537)
7. Bellipanni G, Murakami T & Weinberg ES 2010 Molecular dissection of Otx1 functional domains in the zebrafish embryo. Journal of Cellular Physiology 222 286-293. (doi:10.1002/jcp.21944)
8. Bhaya D, Davison M & Barrangou R 2011 CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annual Review of Genetics 45 273-297. (doi:10.1146/annurev-genet-110410-132430)
9. Bill BR, Petzold AM, Clark KJ, Schimmenti LA & Ekker SC 2009 A primer for morpholino use in zebrafish. Zebrafish 6 69-77. (doi:10.1089/zeb.2008.0555)
10. Boehmler W, Obrecht-Pflumio S, Canfield V, Thisse C, Thisse B & Levenson R 2004 Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish. Developmental Dynamics 230 481-493. (doi:10.1002/dvdy.20075)
11. Boehmler W, Carr T, Thisse C, Thisse B, Canfield VA & Levenson R 2007 D4 dopamine receptor genes of zebrafish and effects of the antipsychotic clozapine on larval swimming behaviour. Genes, Brain and Behavior 6 155-166. (doi:10.1111/j.1601-183X.2006.00243.x)
12. Bourque C & Houvras Y 2011 Hooked on zebrafish: insights into development and cancer of endocrine tissues. Endocrine-Related Cancer 18 R149-R164. (doi:10.1530/ERC-11-0099)
13. Bricaire L, Odou MF, Cardot-Bauters C, Delemer B, North MO, Salenave S, Vezzosi D, Kuhn JM, Murat A, Caron P et al. 2013 Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 98 E403-E408. (doi:10.1210/jc.2012-2789)
14. Burzynski G, Shepherd IT & Enomoto H 2009 Genetic model system studies of the development of the enteric nervous system, gut motility and Hirschsprung's disease. Neurogastroenterology and Motility 21 113-127. (doi:10.1111/j.1365-2982.2008.01256.x)
15. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD et al. 2002 HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nature Genetics 32 676-680. (doi:10.1038/ng1048)
16. Cascon A & Robledo M 2012 MAX and MYC: a heritable breakup. Cancer Research 72 3119-3124. (doi:10.1158/0008-5472.CAN-11-3891)
17. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA et al. 2013 Multiplex genome engineering using CRISPR/Cas systems. Science 339 819-823. (doi:10.1126/science.1231143)
18. Dworakowska D & Grossman AB 2009 Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review Endocrine-Related Cancer 16 45-58. (doi:10.1677/ERC-08-0142)
19. Faggiano A, Ramundo V, Dicitore A, Castiglioni S, Borghi MO, Severino R, Ferolla P, Crino L, Abbruzzese A, Sperlongano P et al. 2012 Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study. Journal of Cellular and Molecular Medicine 16 1563-1572. (doi:10.1111/j.1582-4934.2011. 01438.x)
20. Feitsma H & Cuppen E 2008 Zebrafish as a cancer model. Molecular Cancer Research 6 685-694. (doi:10.1158/1541-7786.MCR-07-2167))
21. Ferone D, Gatto F, Arvigo M, Resmini E, Boschetti M, Teti C, Esposito D & Minuto F 2009 The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology. Journal of Molecular Endocrinology 42 361-370. (doi:10.1677/JME-08-0162)
22. Field HA, Kelley KA, Martell L, Goldstein AM & Serluca FC 2009 Analysis of gastrointestinal physiology using a novel intestinal transit assay in zebrafish. Neurogastroenterology and Motility 21 304-312. (doi:10.1111/j.1365-2982.2008.01234.x)
23. Fieramonti L, Bassi A, Foglia EA, Pistocchi A, D'Andrea C, Valentini G, Cubeddu R, De Silvestri S, Cerullo G & Cotelli F 2012 Time-gated optical projection tomography allows visualization of adult zebrafish internal structures. PLoS ONE 7 e50744. (doi:10.1371/journal.pone.0050744)
24. Fisher S, Grice EA, Vinton RM, Bessling SL & McCallion AS 2006 Conservation of RET regulatory function from human to zebrafish without sequence similarity. Science 312 276-279. (doi:10.1126/science.1124070)
25. Gatto F & Hofland LJ 2011 The role of somatostatin and dopamine D2 receptors in endocrine tumors. Endocrine-Related Cancer 18 R233-R251. (doi:10.1530/ERC-10-0334)
26. Ghotra VP, He S, de Bont H, van der Ent W, Spaink HP, van de Water B, Snaar-Jagalska BE & Danen EH 2012 Automated whole animal bio-imaging assay for human cancer dissemination. PLoS ONE 7 e31281. (doi:10.1371/journal.pone. 0031281)
27. Haldi M, Ton C, Seng WL & McGrath P 2006 Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis 9 139-151. (doi:10.1007/s10456-006-9040-2)
28. Hesselson D, Anderson RM, Beinat M & Stainier DY 2009 Distinct populations of quiescent and proliferative pancreatic b-cells identified by HOTcre mediated labeling. PNAS 106 14896-14901. (doi:10.1073/pnas.0906348106)
29. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JR & Joung JK 2013 Efficient genome editing in zebrafish using a CRISPR-Cas system. Nature Biotechnology 31 227-229. (doi:10.1038/nbt.2501)
30. Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, Chapple JP, Trivellin G, Gueorguiev M, Guegan K et al. 2010 Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Human Mutation 31 950-960. (doi:10.1002/humu.21292)
31. Isogai S, Horiguchi M & Weinstein BM 2001 The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Developmental Biology 230 278-301. (doi:10.1006/dbio.2000.9995)
32. Kajimura S, Aida K & Duan C 2006 Understanding hypoxia-induced gene expression in early development: in vitro and in vivo analysis of hypoxiainducible factor 1-regulated zebra fish insulin-like growth factor binding protein 1 gene expression. Molecular and Cellular Biology 26 1142-1155. (doi:10.1128/MCB.26.3.1142-1155.2006)
33. Khodaei S, O'Brien KP, Dumanski J, Wong FK & Weber G 1999 Characterization of the MEN1 ortholog in zebrafish. Biochemical and Biophysical Research Communications 264 404-408. (doi:10.1006/bbrc.1999.1529)
34. Kim SH, Speirs CK, Solnica-Krezel L & Ess KC 2011 Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cellautonomous functions of mutant tuberin. Disease Models & Mechanisms 4 255-267. (doi:10.1242/dmm.005587)
35. Kim S, Kim JD, Chung AY, Kim HS, Kim YS, Kim MJ, Koun S, Lee YM, Rhee M, Park HC et al. 2012 Antagonistic regulation of PAF1C and p-TEFb is required for oligodendrocyte differentiation. Journal of Neuroscience 32 8201-8207. (doi:10.1523/JNEUROSCI.5344-11.2012)
36. Kim SH, Kowalski ML, Carson RP, Bridges LR & Ess KC 2013 Heterozygous inactivation of tsc2 enhances tumorigenesis in p53 mutant zebrafish. Disease Models & Mechanisms 6 925-933. (doi:10.1242/dmm.011494)
37. Konantz M, Balci TB, Hartwig UF, Dellaire G, Andre MC, Berman JN & Lengerke C 2012 Zebrafish xenografts as a tool for in vivo studies on human cancer. Annals of the New York Academy of Sciences 1266 124-137. (doi:10.1111/j.1749-6632.2012.06575.x)
38. Laycock-van Spyk S, Thomas N, Cooper DN & Upadhyaya M 2011 Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Human Genomics 5 623-690. (doi:10.1186/1479-7364-5-6-623)
39. Lee LM, Seftor EA, Bonde G, Cornell RA & Hendrix MJ 2005 The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Developmental Dynamics 233 1560-1570. (doi:10.1002/dvdy.20471)
40. Lekmine F, Feracci H, Milhaud G, Treilhou-Lahille F & Jeanne N 1999 Expression of laminin-2 by normal and neoplastic rat C cells during the development of medullary thyroid carcinoma. Virchows Archiv 434 325-332. (doi:10.1007/s004280050348)
41. Li P, Shah S, Huang L, Carr AL, Gao Y, Thisse C, Thisse B & Li L 2007 Cloning and spatial and temporal expression of the zebrafish dopamine D1 receptor. Developmental Dynamics 236 1339-1346. (doi:10.1002/dvdy.21130)
42. Lieschke GJ & Currie PD 2007 Animal models of human disease: zebrafish swim into view. Nature Reviews. Genetics 8 353-367. (doi:10.1038/nrg2091)
43. Liu S & Leach SD 2011 Zebrafish models for cancer. Annual Review of Pathology 6 71-93. (doi:10.1146/annurev-pathol-011110-130330)
44. Liu TX, Zhou Y, Kanki JP, Deng M, Rhodes J, Yang HW, Sheng XM, Zon LI & Look AT 2002 Evolutionary conservation of zebrafish linkage group 14 with frequently deleted regions of human chromosome 5 in myeloid malignancies. PNAS 99 6136-6141. (doi:10.1073/pnas.072560099)
45. Liu NA, Jiang H, Ben-Shlomo A, Wawrowsky K, Fan XM, Lin S & Melmed S 2011 Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor. PNAS 108 8414-8419. (doi:10.1073/pnas.1018091108)
46. Lohr H & Hammerschmidt M 2011 Zebrafish in endocrine systems: recent advances and implications for human disease. Annual Review of Physiology 73 183-211. (doi:10.1146/annurev-physiol-012110-142320)
47. Lucini C, D'Angelo L, Patruno M, Mascarello F, de Girolamo P & Castaldo L 2011 GDNF family ligand RET receptor in the brain of adult zebrafish. Neuroscience Letters 502 214-218. (doi:10.1016/j.neulet.2011.07.047)
48. Lund EL, Thorsen C, Pedersen MW, Junker N & Kristjansen PE 2000 Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro. Clinical Cancer Research 6 4287-4291.
49. Ma AC, Lee HB, Clark KJ & Ekker SC 2013 High efficiency in vivo genome engineering with a simplified 15-RVD GoldyTALEN design. PLoS ONE 8 e65259. (doi:10.1371/journal.pone.0065259)
50. Malafoglia V, Bryant B, Raffaeli W, Giordano A & Bellipanni G 2013 The zebrafish as a model for nociception studies. Journal of Cellular Physiology 228 1956-1966. (doi:10.1002/jcp.24379)
51. Marcos-Gutierrez CV, Wilson SW, Holder N & Pachnis V 1997 The zebrafish homologue of the ret receptor and its pattern of expression during embryogenesis. Oncogene 14 879-889. (doi:10.1038/sj.onc.1201048)
52. Marques IJ, Weiss FU, Vlecken DH, Nitsche C, Bakkers J, Lagendijk AK, Partecke LI, Heidecke CD, Lerch MM & Bagowski CP 2009 Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer 9 128. (doi:10.1186/1471-2407-9-128)
53. Mimeault M & Batra SK 2013 Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials. Drug Discovery Today 18 128-140. (doi:10.1016/j.drudis.2012.08.002)
54. Moens CB, Donn TM, Wolf-Saxon ER & Ma TP 2008 Reverse genetics in zebrafish by TILLING. Briefings in Functional Genomics & Proteomics 7 454-459. (doi:10.1093/bfgp/eln046)
55. Moore FE & Langenau DM 2012 Through the looking glass: visualizing leukemia growth, migration, and engraftment using fluorescent transgenic zebrafish. Advances in Hematology 2012 478164. (doi:10.1155/2012/478164)
56. Moro E, Vettori A, Porazzi P, Schiavone M, Rampazzo E, Casari A, Ek O, Facchinello N, Astone M, Zancan I et al. 2013 Generation and application of signaling pathway reporter lines in zebrafish. Molecular Genetics and Genomics 288 231-242. (doi:10.1007/s00438-013-0750-z)
57. Nicoli S & Presta M 2007 The zebrafish/tumor xenograft angiogenesis assay. Nature Protocols 2 2918-2923. (doi:10.1038/nprot.2007.412)
58. Nicoli S, Ribatti D, Cotelli F & Presta M 2007 Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Research 67 2927-2931. (doi:10.1158/0008-5472.CAN-06-4268)
59. Ocampo Daza D, Sundstrom G, Bergqvist CA & Larhammar D 2012 The evolution of vertebrate somatostatin receptors and their gene regions involves extensive chromosomal rearrangements. BMC Evolutionary Biology 12 231. (doi:10.1186/1471-2148-12-231)
60. Olias G, Viollet C, Kusserow H, Epelbaum J & Meyerhof W 2004 Regulation and function of somatostatin receptors. Journal of Neurochemistry 89 1057-1091. (doi:10.1111/j.1471-4159.2004.02402.x)
61. Pelengaris S & Khan M 2001 Oncogenic co-operation in b-cell tumorigenesis. Endocrine-Related Cancer 8 307-314. (doi:10.1677/erc.0.0080307)
62. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J & Atkinson MJ 2006 Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. PNAS 103 15558-15563. (doi:10.1073/pnas.0603877103)
63. Petrangolini G, Cuccuru G, Lanzi C, Tortoreto M, Belluco S, Pratesi G, Cassinelli G & Zunino F 2006 Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1. Biochemical Pharmacology 72 405-414. (doi:10.1016/j.bcp.2006. 05.002)
64. Pichler FB, Laurenson S, Williams LC, Dodd A, Copp BR & Love DR 2003 Chemical discovery and global gene expression analysis in zebrafish. Nature Biotechnology 21 879-883. (doi:10.1038/nbt852)
65. Pistocchi A, Gaudenzi G, Carra S, Bresciani E, Del Giacco L & Cotelli F 2008 Crucial role of zebrafish prox1 in hypothalamic catecholaminergic neurons development. BMC Developmental Biology 8 27. (doi:10.1186/1471-213X-8- 27)
66. Porazzi P, Calebiro D, Benato F, Tiso N & Persani L 2009 Thyroid gland development and function in the zebrafish model. Molecular and Cellular Endocrinology 312 14-23. (doi:10.1016/j.mce.2009.05.011)
67. Quaife NM, Watson O & Chico TJ 2012 Zebrafish: an emerging model of vascular development and remodelling. Current Opinion in Pharmacology 12 608-614. (doi:10.1016/j.coph.2012.06.009)
68. Rampazzo E, Persano L, Pistollato F, Moro E, Frasson C, Porazzi P, Della Puppa A, Bresolin S, Battilana G, Indraccolo S et al. 2013 Wnt activation promotes neuronal differentiation of glioblastoma. Cell Death & Disease 4 e500. (doi:10.1038/cddis.2013.32)
69. Richard S, Gardie B, Couve S & Gad S 2013 Von Hippel-Lindau: how a rare disease illuminates cancer biology. Seminars in Cancer Biology 23 26-37. (doi:10.1016/j.semcancer.2012.05.005)
70. Rios Y, Melmed S, Lin S & Liu NA 2011 Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion. PLoS Genetics 7 e1001271. (doi:10.1371/journal.pgen.1001271)
71. van Rooijen E, Voest EE, Logister I, Bussmann J, Korving J, van Eeden FJ, Giles RH & Schulte-Merker S 2010 von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish. Disease Models & Mechanisms 3 343-353. (doi:10.1242/dmm.004036)
72. van Rooijen E, Santhakumar K, Logister I, Voest E, Schulte-Merker S, Giles R & van Eeden F 2011 A zebrafish model for VHL and hypoxia signaling. Methods in Cell Biology 105 163-190.
73. Rovira M, Huang W, Yusuff S, Shim JS, Ferrante AA, Liu JO & Parsons MJ 2011 Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation. PNAS 108 19264-19269. (doi:10.1073/pnas.1113081108)
74. Ruscica M, Arvigo M, Steffani L, Ferone D & Magni P 2013 Somatostatin, somatostatin analogs and somatostatin receptor dynamics in the biology of cancer progression. Current Molecular Medicine 13 555-571. (doi:10.2174/1566524011313040008)
75. Santhakumar K, Judson EC, Elks PM, McKee S, Elworthy S, van Rooijen E, Walmsley SS, Renshaw SA, Cross SS & van Eeden FJ 2012 A zebrafish model to study and therapeutically manipulate hypoxia signaling in tumorigenesis. Cancer Research 72 4017-4027. (doi:10.1158/0008-5472.CAN-11-3148)
76. Santoriello C & Zon LI 2012 Hooked! Modeling human disease in zebrafish. Journal Clinical Investigation 122 2337-2343. (doi:10.1172/JCI60434)
77. Scoazec JY 2013 Angiogenesis in neuroendocrine tumors: therapeutic applications. Neuroendocrinology 97 45-56. (doi:10.1159/000338371)
78. Sharretts JM, Kebebew E & Simonds WF 2010 Parathyroid cancer. Seminars in Oncology 37 580-590. (doi:10.1053/j.seminoncol.2010.10.013)
79. Shin J, Padmanabhan A, de Groh ED, Lee JS, Haidar S, Dahlberg S, Guo F, He S, Wolman MA, Granato M et al. 2012 Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development. Disease Models & Mechanisms 5 881-894. (doi:10.1242/dmm.009779)
80. Shive HR 2013 Zebrafish models for human cancer. Veterinary Pathology 50 468-482. (doi:10.1177/0300985812467471)
81. Siekmann AF & Lawson ND 2007 Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445 781-784. (doi:10.1038/nature05577)
82. Stoletov K, Montel V, Lester RD, Gonias SL & Klemke R 2007 Highresolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. PNAS 104 17406-17411. (doi:10.1073/pnas. 0703446104)
83. Taylor AM & Zon LI 2009 Zebrafish tumor assays: the state of transplantation. Zebrafish 6 339-346. (doi:10.1089/zeb.2009.0607)
84. Tehrani Z & Lin S 2011 Endocrine pancreas development in zebrafish. Cell Cycle 10 3466-3472. (doi:10.4161/cc.10.20.17764)
85. Teule A & Casanovas O 2012 Relevance of angiogenesis in neuroendocrine tumors. Targeted Oncology 7 93-98. (doi:10.1007/s11523-012-0217- x)
86. Tobia C, De Sena G & Presta M 2011 Zebrafish embryo, a tool to study tumor angiogenesis. International Journal of Developmental Biology 55 505-509. (doi:10.1387/ijdb.103238ct)
87. Tobia C, Gariano G, De Sena G & Presta M 2013 Zebrafish embryo as a tool to study tumor/endothelial cell cross-talk. Biochimica et Biophysica Acta 1832 1371-1377. (doi:10.1016/j.bbadis.2013.01.016)
88. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J & Hendrix MJ 2006 Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nature Medicine 12 925-932. (doi:10.1038/nm1448)
89. Toro S, Wegner J, Muller M, Westerfield M & Varga ZM 2009 Identification of differentially expressed genes in the zebrafish hypothalamic-pituitary axis. Gene Expression Patterns 9 200-208. (doi:10.1016/j.gep.2008.12.007)
90. Vitale G, Caraglia M, Ciccarelli A, Lupoli G, Abbruzzese A & Tagliaferri P 2001 Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer 91 1797-1808. (doi:10.1002/1097- 0142(20010501)91:9<1797::AID-CNCR1199>3.0.CO;2-P)
91. Vlotides G, Eigler T & Melmed S 2007 Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocrinology Reviews 28 165-186. (doi:10.1210/er.2006-0042)
92. Vogt A, Cholewinski A, Shen X, Nelson SG, Lazo JS, Tsang M & Hukriede NA 2009 Automated image-based phenotypic analysis in zebrafish embryos. Developmental Dynamics 238 656-663. (doi:10.1002/dvdy.21892)
93. Wenner M 2009 The most transparent research. Nature Medicine 15 1106-1109. (doi:10.1038/nm1009-1106)
94. Wenzlau JM, Garl PJ, Simpson P, Stenmark KR, West J, Artinger KB, Nemenoff RA & Weiser-Evans MC 2006 Embryonic growth-associated protein is one subunit of a novel N-terminal acetyltransferase complex essential for embryonic vascular development. Circulation Research 98 846-855. (doi:10.1161/01.RES.0000214539.86593.7a)
95. White R, Rose K & Zon L 2013 Zebrafish cancer: the state of the art and the path forward. Nature Reviews. Cancer 13 624-636. (doi:10.1038/nrc3589)
96. Yang HW, Kutok JL, Lee NH, Piao HY, Fletcher CD, Kanki JP & Look AT 2004 Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Research 64 7256-7262. (doi:10.1158/0008-5472.CAN-04-0931)
97. Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J & Weinstein BM 2006 Live imaging of lymphatic development in the zebrafish. Nature Medicine 12 711-716. (doi:10.1038/nm1427)
98. Zhu S, Lee JS, Guo F, Shin J, Perez-Atayde AR, Kutok JL, Rodig SJ, Neuberg DS, Helman D, Feng H et al. 2012 Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. Cancer Cell 21 362-373. (doi:10.1016/j.ccr.2012.02. 010)